Cyclooxygenase inhibition in mice heightens adaptive- and innate-type responses against inhaled protease allergen and IL-33

Allergy. 2019 Nov;74(11):2237-2240. doi: 10.1111/all.13831. Epub 2019 Jul 15.
No abstract available

Keywords: IL-33; asthma; murine models; nonsteroidal anti-inflammatory drug; protease allergen.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / drug effects*
  • Allergens / immunology*
  • Animals
  • Asthma / drug therapy
  • Asthma / immunology
  • Asthma / metabolism
  • Asthma / pathology
  • Cyclooxygenase Inhibitors / pharmacology*
  • Cytokines / metabolism
  • Disease Models, Animal
  • Immunity, Innate / drug effects*
  • Interleukin-13 / immunology*
  • Mice
  • Peptide Hydrolases / immunology*
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism

Substances

  • Allergens
  • Cyclooxygenase Inhibitors
  • Cytokines
  • Interleukin-13
  • Prostaglandin-Endoperoxide Synthases
  • Peptide Hydrolases